Real-time enrollment status for this non-small cell lung cancer clinical trial
Current Status
Recruiting
Checked: September 1, 2026 at 12:06 AM UTC
| NCT Number | NCT06855771 |
| Recruiting Status | Recruiting |
| Condition | Non-small Cell Lung Cancer |
| Phase | PHASE2 |
| Target Enrollment | 130 participants |
| Active Locations | 12 sites in the US |
| Sponsor | Bristol-Myers Squibb |
| Last Updated on CT.gov | June 10, 2026 (Jun 10, 2026) |
As of September 1, 2026: Clinical trial NCT06855771 is currently recruiting participants. This phase2 study for non-small cell lung cancer is actively seeking new participants at 12 locations across the United States. The study is sponsored by Bristol-Myers Squibb. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06855771 is actively recruiting participants as of September 1, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 12 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06855771 was last updated Jun 10, 2026 (June 10, 2026). HelloStudys verifies this status automatically.